 Atai Life Sciences NASDAQ:ATAI, a biotech company in the psychedelic space, had its Nasdaq debut on Friday. The Berlin-based company is joining an exclusive group of start-ups in the psychedelics sector to IPO this year on the Nasdaq, including MindMed NASDAQ:MNMD and Compass Pathways NASDAQ:CMPS. 